Employees

SICRIS: 14575
E-mail: mcemazar(at)onko-i.si
Phone: 00386 1 587 95 44
Fax: 00386 1 587 94 34

Professor Dr. Maja Cemazar is currently the head of  Department for research and education of the Institute of Oncology Ljubljana and a Full Professor at the Faculty of Health Sciences, University of Primorska. She is also an active researcher in the Department of Experimental Oncology at the Institute of Oncology Ljubljana and at the Research Group of the Faculty of Health Sciences Izola. Her research interest is translational research of electroporation based technology; predominantly electroporation-based gene transfer and drug delivery.

SICRIS: 08800
E-mail: gsersa(at)onko-i.si
Phone: 00386 1 587 94 34
Fax: 00386 1 587 94 34

Acad. Prof. Dr. Gregor Sersa is currently the deputy head of the Department of Experimental Oncology, at the Institute of Oncology Ljubljana and a Full Professor at the Faculty of Health Sciences, University of Ljubljana. Since 2021 he is full member of Slovenian Academy of Sciences and Arts and member of presidency of SASA. His research interest is translational research of electroporation based technology; predominantly electroporation-based gene transfer and drug delivery.

SICRIS: 19058
E-mail: skranjc(at)onko-i.si
Phone: 00386 1 587 96 07

Simona`s research is focused on gene therapy and electrochemotherapy combined with radiotherapy, preclinical studies in vitro and in vivo.

SICRIS: 28387
E-mail: ukamensek(at)onko-i.si
Phone: 00386 1 587 94 37

Urska’s main research expertise lie in plasmid construction and gene therapy, principally gene electrotransfer. Currently, her research focuses on immunomodulatory therapies targeting cancer.

SICRIS: 33227
E-mail: tjesenko(at)onko-i.si
Phone: 00386 1 587 95 45

Tanja's research is focused on gene therapy and basic radiobiology.

SICRIS: 36367
E-mail: ulampreht(at)onko-i.si
Phone: 00386 1 587 94 37

Urša is investigating the use of IL-12 gene transfer and electrochemotherapy in preclinical research and translational studies in spontaneous tumors in dogs.

SICRIS: 32175
E-mail: bmarkelc(at)onko-i.si
Phone: 00386 1 587 95 45

Bostjan's research is focused on combining radiotherapy with immune gene therapy.

SICRIS: 34373
E-mail: mbosnjak(at)onko-i.si
Phone: 00386 1 587 95 45

Masa's research is focused on DNA-specific pattern recognition receptor activation following DNA electroporation.

SICRIS: 38223
E-mail: kursic(at)onko-i.si
Phone: 00386 1 587 94 37

Katja’s research work covers antitumor and immunomodulatory effects of electrochemotherapy, gene electrotransfer of plasmids coding for IL-12 and other immunotherapies.

SICRIS: 37534
E-mail: kznidar(at)onko-i.si
Phone: 00386 1 587 94 37

Katarina’s research is focused on activation of cytosolic DNA sensors after gene transfer of pDNA into tumor and normal cells in vitro and in vivo.

SICRIS: 51848
E-mail: tbozic(at)onko-i.si
Phone: 00386 587 95 45

Tim is researching the effects of chemokines on the activation of anti-tumor immune response. He is using gene electrotransfer to deliver plasmid DNA encoding for chemokines into the tumors.

SICRIS: 51873
E-mail: ukesar(at)onko-i.si
Phone: 00386 1 587 95 45

Urša's work is based on studying different cell lines in combination with different types and doses of cytostatic drugs and different doses of irradiation.

SICRIS: 55825
E-mail: isantek(at)onko-i.si
Phone: 00386 1 587 94 37

Iva's research is focused on the effects of irradiation on tumor vasculature and the interactions between tumor vasculature and immune cells.

SICRIS: 53504
E-mail: tkomel(at)onko-i.si
Phone: 00386 1 587 94 37

Tilen is researching the anti-tumor effects of gene electrotransfer of plasmids encoding interleukin 2 and 12.

SICRIS: 54718
E-mail: zmodic(at)onko-i.si
Phone: 00386 1 587 95 45

Ziva's research is focused on combining different doses of radiation with immunotherapy. She studies the anti-tumor response to this combination approach and its potential to reprogram the tumor microenvironment.

SICRIS: 55824
E-mail: avrabic(at)onko-i.si
Phone: 00386 1 587 94 37

Ajda's research is focused on the plasmid DNA induced activation of cytosolic DNA sensors in the cells and the how this influences the immune system.

SICRIS: 57050
E-mail: skupcic(at)onko-i.si
Phone: 00386 1 587 94 37

Saša is researching electrochemotherapy and its effect on osteosarcoma cells.

E-mail: mklemencic(at)onko-i.si
Phone: 00386 1 587 93 69

E-mail: tvalant(at)onko-i.si
Phone: 00386 1 587 95 45